Results 21 to 30 of about 29,905 (235)

Long-term outcomes of surgery for obstructive hypertrophic cardiomyopathy in a pediatric cohortCentral MessagePerspective

JTCVS Open, 2023
Background: Septal reduction therapy via septal myectomy or a modified Konno procedure is the mainstay of therapy for drug-refractory obstructive hypertrophic cardiomyopathy (HCM), although outcomes data on septal myectomy in pediatric patients are ...
Stephanie N. Nguyen, MD, Megan M. Chung, BA, Alice V. Vinogradsky, BA, Marc E. Richmond, MD, MS, Warren A. Zuckerman, MD, Andrew B. Goldstone, MD, PhD, Emile A. Bacha, MD   +6 more
doaj   +1 more source

Endocardial Radiofrequency Ablation vs. Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis

Frontiers in Surgery, 2022
BackgroundSeptal myectomy (SM) has been the gold standard therapy for most patients with hypertrophic obstructive cardiomyopathy (HOCM). Endocardial radiofrequency ablation of septal hypertrophy (ERASH) is a novel treatment for septal reduction. We aimed
Tao Jiang, Bingyu Huang, Shengqi Huo, Lulu Monica Mageta, Junyi Guo, Jiagao Lv, Li Lin   +6 more
doaj   +1 more source

Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy?

Türk Kardiyoloji Derneği Arşivi, 2018
Hypertrophic obstructive cardiomyopathy is an inheritable cardiac disease that typically manifests with an increased left ventricular outflow tract gradient.
Elnur Alizade, Sabahattin Gündüz, Ahmet Güner, Khagani Isgandarov, Selçuk Pala   +4 more
doaj   +1 more source

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy

Türk Kardiyoloji Derneği Arşivi, 2017
Summary– Septal reduction therapy (SRT) is the accepted therapeutic option for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). At this time, surgical septal myectomy is the gold standard method, but alcohol septal ablation is an acceptable ...
Tolga Aksu, Tümer Erdem Güler, Kıvanç Yalın, Şükriye Ebru Gölcük, Kazım Serhan Özcan   +4 more
doaj   +1 more source

Septal reduction therapies in hypertrophic cardiomyopathy: comparison of surgical septal myectomy and alcohol septal ablation

Interventional Cardiology, 2014
Abstract Left ventricular outflow tract obstruction, either resting or labile, occurs in approximately 70% of patients with hypertrophic cardiomyopathy and is a major cause of symptoms. In patients with obstructive physiology and medically refractory symptoms, septal myectomy and alcohol septal ablation reduce the left ventricular outflow tract ...
Jeffrey B Geske, Kyle W Klarich, Steve R Ommen, Hartzell V Schaff, Rick A Nishimura   +4 more
openaire   +1 more source

Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients

Transplantation Direct, 2022
Background. Hypertrophic cardiomyopathy (HCM) in pediatric solid organ transplant recipients has been reported in association with use of calcineurin inhibitors.
Nosheen Reza, MD, Alejandro De Feria, MD, Teresa Wang, MD, Jessica L. Chowns, CGC, Lily Hoffman-Andrews, CGC, Jessica Kim, BS, Nicole Hornsby, CRNP, Amy Marzolf, CRNP, Pavan Atluri, MD, Howard C. Herrmann, MD, Anjali Tiku Owens, MD   +10 more
doaj   +1 more source

Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy and Sudden Death [PDF]

Circulation: Cardiovascular Interventions, 2010
There is a subset of patients with hypertrophic cardiomyopathy and left ventricular outflow tract obstruction who have severely limiting symptoms despite optimal medical therapy.1 Septal reduction therapy, consisting of a surgical procedure (septal myectomy) or a catheter-based therapy (alcohol septal ablation), has been used to treat this subset of ...
Rick A. Nishimura, Steve R. Ommen
openaire   +1 more source

Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis

American Heart Journal Plus, 2022
Study objective: Hypertrophic cardiomyopathy (HCM) is a genetic disease that can cause left ventricular outflow tract (LVOT) obstruction. This study analyzed the efficacy of radiofrequency ablation (RA) in improving clinical and hemodynamic factors in ...
Camila Cássia Canzi, Edivalde Ribeiro do Prado Júnior, Antônio da Silva Menezes Júnior, Aline Lazara Rezende, Silvia Marçal Botelho, Luciana da Ressurreição Santos   +5 more
doaj   +1 more source

Local myocardial stiffness variations identified by high frame rate shear wave echocardiography

Cardiovascular Ultrasound, 2020
Background Shear waves are generated by the closure of the heart valves. Significant differences in shear wave velocity have been found recently between normal myocardium and disease models of diffusely increased muscle stiffness.
Mihai Strachinaru, Johan G. Bosch, Arend F. L. Schinkel, Michelle Michels, Lida Feyz, Nico de Jong, Marcel L. Geleijnse, Hendrik J. Vos   +7 more
doaj   +1 more source

Severe and Apparently Irreversible Pulmonary Arterial Hypertension in a Patient with Ostium Secundum Atrial Septal Defect – A Successful Case of Treat and Close Strategy

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2022
Irreversible pulmonary arterial hypertension is considered a contraindication for surgical or percutaneous closure of atrial septal defects (ASD) due to risk of right heart failure.
Alexandra Briosa, Filipa Ferreira, João Santos, Sofia Alegria, Maria José Loureiro, Débora Repolho, Hélder Pereira   +6 more
doaj   +1 more source